Datroway Improves Survival in First-Line Treatment of Metastatic Triple-Negative Breast Cancer

FDA Approves Tecentriq–Zepzelca Combo as First-Line Maintenance Therapy for ES-SC Lung Cancer

The VAPOR 2 Trial and the Potential of Water Vapor Ablation in Prostate Cancer Treatment

DESTINY-Breast05: Enhertu Outperforms T-DM1 in High-Risk HER2+ Early Breast Cancer

Dr. Eleni Lagkadinou Discusses How AbbVie Is Advancing Targeted Innovation for HT Cancers

FDA Approves Imlunestrant for ESR1-Mutated Metastatic Breast Cancer

Giredestrant Plus Everolimus Improves PF Survival in ER+ Advanced Breast Cancer

Sugary Drinks Drive Colorectal Cancer Metastasis via SORD Pathway, Study Finds

NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer

EMA’s CHMP Backs Subcutaneous Pembrolizumab in Head and Neck Cancer

Climate-Driven Health Risks to Put $1.5 Trillion in Productivity at Stake by 2050

GSK to invest $30 billion in R&D and Manufacturing in the US over next 5 years

The Role of Third-Generation TKIs in Overcoming Chronic Myeloid Leukemia Resistance

FDA Grants Breakthrough Status to Raludotatug Deruxtecan for Refractory Ovarian Cancer

SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma

The V Foundation and CVC Collaborate to Advance Breast Cancer Vaccine Research

CVC and V Foundation Fuel $500K Grant for Next Phase of Breast Cancer Vaccine Research

The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines

ONCOLife’s New Edition Is Live with Breakthroughs in Cancer Research

FDA Grants Breakthrough Status to Izalontamab Brengitecan for EGF+ Lung Cancer

The First FDA-Cleared Blood Test for Alzheimer’s Diagnosis Now Available on the Market

First Patient Enrolled for Aliya® PEF Tumor Ablation of Lung/Liver Soft-Tissue Lesions

Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells

Bacteria Cloak Viruses to Safely Deliver Cancer-Killing Payloads into Solid Tumors

FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis

RNA Isoform RUNX1C Identified as Molecular 'Switch' Behind Chemoresistance in Blood Cancer

FDA Approves Papzimeos, First Immunotherapy for Recurrent Respiratory Papillomatosis

mRNA Vaccines Plus Checkpoint Inhibitors Shows Curative Potential in Gastric Cancer

Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission

Breaking the Molecular Link Between Alcohol and Pancreatic Cancer by Targeting CREB